Genetic Technologies Net Income

Genetic Technologies (GENE) currently reports a net income of $-22M as of June 2024. That compares with $-15M in the prior-year period — down 47.5% year over year. That is below the Healthcare sector average of $16B. Use the charts on this page to explore Genetic Technologies's net income history and peer comparisons.

Genetic Technologies's net income decreased from $-15M to $-22M — a 47.5% year-over-year decrease (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Genetic Technologies's net income of $-22M is lower than the Healthcare sector average of $16B. That is roughly 100.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Genetic Technologies reported $-22M in net income as of June 2024. That compares with $-15M in the prior-year period — down 47.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-22M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $16B. From there, open related valuation or income-statement pages for Genetic Technologies, and consider following GENE for alerts when major investors trade the stock.